Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities:
Net income/(loss)	$ 15,515	$ (14,609)
Adjustments to reconcile net income/(loss) to net cash flows from operating activities
Depreciation	467	253
Accretion of debt discount and loan costs	231	11,441
Amortization of intangible assets	5,248	5,084
Provision for inventory obsolescence	(297)	57
Stock-based compensation expense	7,845	3,978
Changes in assets and liabilities:
Accounts receivable	(5,040)	(19,795)
Inventories	(7,278)	(5,416)
Prepaid expenses and other assets	(1,985)	(1,686)
Accounts payable and accrued liabilities	(701)	14,844
Taxes payable	(40)	0
Net cash flows provided by/(used in) operating activities	13,965	(5,849)
Investing activities:
Product acquisitions	0	(20,674)
Acquisitions of equipment	0	(79)
Net cash flows used in investing activities	0	(20,753)
Financing activities:
Proceeds from issuance of common stock	0	48,000
Equity issuance costs	0	(410)
Proceeds from notes payable	20,000	60,000
Proceeds from exercise of stock options	2,761	1,193
Payment on note payable	0	(67,346)
Loss on refinancing of former debt	0	(2,794)
Payment on deferred financing fees	(437)	0
Net cash flows provided by financing activities	22,324	38,643
Net change in cash and cash equivalents	36,289	12,041
Cash and cash equivalents at beginning of period	63,888	43,822
Cash and cash equivalents at end of period	100,177	55,863
Cash paid for interest	$ 5,037	$ 3,831